Interview
Physicians and Institutions Transform the Lives of Nano-rare Patients
with Olivia Kim-McManus, M.D.
April 17, 2024
Research physicians and their associated institutions are monumental to the mission of the n-Lorem Foundation and are truly transformational to the lives of the nano-rare patients they treat. Olivia Kim-McManus, M.D., was one of four physician panelists at our first Colloquium who participated in “A Physician’s Perspective on n-Lorem and Nano-rare”. Hear Olivia’s outlook on nano-rare patients and how the support of an institution like UCSD Rady Children’s Hospital makes all the difference.
On This Episode We Discuss:
- 1:55 When Dr. McManus became interested in pediatric neurology and epilepsy
- 4:00 What ion channels do and why they play a role in epilepsy
- 5:17 How often is epilepsy genetically caused?
- 6:52 Why Dr. McManus and Rady Children’s Hospital choose to invest time and resources in helping nano-rare patients
- 11:50 Bringing people together for a single forum at the Nano-rare Patient Colloquium inspires collaboration between groups
- 14:43 The importance of a network of treating physicians and institutions and sharing experiences and lessons learned
- 17:58 Interest within Rady Children’s Hospital regarding nano-rare patient treatment and ASOs
- 21:45 A Physician’s Perspective on n-Lorem and Nano-rare
Watch on YouTube:
Dr. Olivia Kim-McManus is an Associate Professor of Neurosciences at UC San Diego and Pediatric Neurologist at Rady Children’s Hospital with additional ABPN Board-certified subspecializations in Epilepsy and Clinical Neurophysiology. She received her undergraduate degree in Neurosciences at Columbia University in New York City and medical degree at George Washington University Children’s National Medical Center. She specializes in treating children with medically intractable epilepsy due to rare genetic etiologies requiring targeted genetic therapies or epilepsy surgery. She is the Director of the Batten’s Disease Neuro-infusion Program at Rady Children’s Hospital where she delivers intraventricular cerliponase-alfa enzyme replacement therapy via Ommaya reservoir targeted for disease modifying therapy for rare pediatric genetic disease. Dr. Kim-McManus is Neurology Section Vice Chief of Medical Staff Executive Committee at Rady Children’s Hospital, ACGME Epilepsy Fellowship Associate Program Director at UCSD, Epilepsy Foundation San Diego Professional Advisory Board member, Rady Children’s Insitute for Genomic Medicine clinical investigator, and UCSD Altman Clinical and Translational Research Institute Scientific Review Board member.
Credits
Hosted by: Dr. Stan Crooke.
Videographer: Jon Magnuson of Mighty One Productions.
Producers: Colin Delaney, Kira Dineen, Jon Magnuson, Andrew Serrano and Amy Williford.
More from n-Lorem:
See what else we are up to on Twitter, Instagram, Facebook, Linked In, YouTube and our website, nlorem.org. If you enjoy this episode, please rate and review us, as it helps others find our podcast. Questions/inquiries can be sent to [email protected].
Listen to our next interview:
We cannot do
this alone
Together we are changing the world—
one patient at a time
We hope that you join us on this journey to discover, develop and provide individualized antisense medicines for free for life for nano-rare patients. The ultimate personalized medicine approach – for free, for life.
Follow us on social for updates on our latest efforts